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Previewsderepressed IIIb to interfere with IIIc inclu-
sion in hMSCs. Luco et al. (2010) next
extended the analysis genome-wide,
showing that a significant portion of
splicing events regulated by PTB were
also regulated by MRG15. The authors
found that the splicing events regulated
by both PTB and MRG15 were similarly
affected in response to RNAi against
PTB or MRG15. A complete overlap
between PTB and MRG15 targets is not
expected because many PTB-dependent
events may not need additional modula-
tion by MRG15, whereas other MRG15-
dependent events might be coupled with
different splicing regulators. These ques-
tions can now be further pursued by
comparing genome-wide MRG15 bind-
ing with the recent genome-wide map
of PTB binding on RNA (Xue et al.,
2009). Interestingly, H3K4me3 distribu-
tion across genes exhibits an opposite
profile to H3K36me3 between PNT2 and
hMSCs, and overexpression of a methyl-
transferase for H3K4me3 reduced IIIc
inclusion by a mechanism that remains
elusive. Furthermore, H3K9me1, a histone
mark generally linked to gene repression,
is selectively enriched on IIIb in PNT2 cells338 Developmental Cell 18, March 16, 2010 ªrelative to hMSCs, raising the possibility
that RNA polymerase II pauses at IIIb to
favor its selection in epithelial cells. These
observations leave open a long list of
questions to be pursued in future studies.
Collectively, the findings of Luco et al.
(2010) demonstrate a clear link between
chromatin features and regulated splic-
ing. We may be looking at just the tip of
the chromatin modification iceberg, con-
sidering the potential combinatory influ-
ence of nucleosome positioning on the
kinetic coupling between transcription
and splicing, appearance of specific cis-
acting elements from nascent RNA, and
recruitment of splicing regulators that
may act in a position- and context-depen-
dent manner. Clearly, complete elucida-
tion of the splicing code must now
consider the contribution of the histone
code. Indeed, it has been reported that
there is increased accuracy in the predic-
tion of splice site usage when information
about nucleosome enrichment is added
to exon prediction programs (Spies
et al., 2009). However, the increase was
relatively small, suggesting a long journey
ahead of us in predicting the splicing
code.2010 Elsevier Inc.REFERENCES
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In this issue of Developmental Cell, Sakano et al. describe a novel mechanism of how a key lymphocyte tran-
scription factor crosstalks to Notch signaling during embryonic development and thereby selectively inhibits
Notch-activated target genes to allow proper left-right patterning.The Notch signaling pathway is recur-
rently used during development in many
cell types and tissues to regulate pro-
cesses such as differentiation, prolifera-
tion, and survival. The signaling cascade
appears to be very simple: binding of
extracellular ligands to Notch receptors
on neighboring cells induces the proteo-lytic cleavage and release of the Notch
intracellular domain (NICD). NICD translo-
cates to the nucleus, heterodimerizes
with the transcription factor CSL (CBF-1
for humans, Suppressor of hairless for
Drosophila, and LAG-1 forCaenorhabditis
elegans, also known as RBP-J in the
mouse), and recruits coactivators, includ-ing Mastermind-like proteins, to induce
transcription of target genes (Bray,
2006). A multitude of Notch target genes
have been identified, some of which are
cell type specific, while others are acti-
vated in many cell types and develop-
mental processes. How Notch signaling
activates only selected target genes
Developmental Cell
Previewswhile others are not activated despite the
presence of CSL binding sites in
their promoters or enhancers is mostly
unknown. In this issue of Developmental
Cell, Sakano et al. (2010) identify the tran-
scriptional repressor B cell leukemia/
lymphoma 6 protein (BCL6) as a protein
that interacts with components of the
Notch-specific transcription machinery
to selectively repress certain Notch target
genes to allow proper establishment of
left-right (LR) asymmetry during Xenopus
development.
On the exterior, vertebrates are essen-
tially bilaterally symmetrical; however,
their interiors exhibit multiple asymme-
tries, exemplified by the LR-asymmetric
positions of many organs and the
coiling of the intestine (Raya and Izpisu´a
Belmonte, 2006). The critical elements in
breaking symmetry take place at the
node, an important organizer structure;
LR asymmetry is subsequently trans-
duced to the lateral plate mesoderm
(LPM), which serves as a global conveyor
of LR-asymmetric information along the
body axis. During establishment of LR
asymmetry, Nodal expression around
the node is directly activated by Notch
signaling from a specific enhancer ele-
ment present in the Nodal gene (Krebs
et al., 2003; Raya et al., 2003). This
process is a crucial step in initiating LR
asymmetry, because diverse mutations
affecting the Notch pathway cause LR
patterning defects characterized by the
absence of Nodal expression in the peri-
nodal region and the LPM (Krebs et al.,
2003; Raya et al., 2003). Moreover, Nodal
initiates the expression of Pitx2, a tran-
scription factor essential for LR patterning
in the LPM (Raya and Izpisu´a Belmonte,
2006). However, Pitx2 expression is also
induced in Notch mutant embryos lacking
Nodal function, indicating that Pitx2 is
regulated by both Nodal-dependent and
-independent mechanisms (Krebs et al.,
2003; Raya et al., 2003). It is conceivable
that Notch signaling is needed at the initial
phase of LR patterning to induce Nodal
expression, whereas at later stages Notch
needs to be inhibited to allow Pitx2
expression.
To gain further insight into how Notch
signaling might regulate transcription
during embryogenesis, Sakano et al.
(2010) used an immunoprecipitation strat-
egy followed by mass spectrometry anal-
ysis to identify novel transcriptional regu-lators that can interact with the ankyrin
repeat domain of NICD. The authors
thereby identified BCL6 as a NICD-inter-
acting protein. BCL6 is a transcriptional
repressor that was first identified as a
proto-oncogene frequently expressed in
non-Hodgkin’s lymphomas as a conse-
quence of chromosomal translocations
(Pasqualucci et al., 2003). Genetic mouse
studies revealed important functions
for BCL6 during T and B lymphocyte dif-
ferentiation, including the regulation of
germinal B cell differentiation to generate
long-lived antibody-secreting plasma
cells from antigen-specific B cells (Crotty
et al., 2010).
Sakano et al. (2010) performed elegant
Morpholino-mediated knockdown and
rescue experiments and thereby estab-
lished a role for BCL6 in LR patterning of
Xenopus embryos. Moreover, they linked
BCL6 to the Nodal-Pitx2 axis and showed
that BCL6 inhibits Notch signaling, which
is necessary to maintain Pitx2 expression.
BCL6-mediated inhibition of Notch sig-
naling is achieved by direct binding to
NICD and by association with corepres-
sors such as BCL6-corepressor (BCoR).
This process prevents the recruitment of
MAM1 (the ortholog of Mastermind-like
proteins) into the Notch-specific tran-
scription complex. Most notably, the
authors showed that BCL6 is not a
general inhibitor of Notch signaling, but
instead selectively inhibits certain Notch
target genes such as enhancer of split
related 1 (ESR1) while other target genes
including Hairy2 remain activated. The
specificity of Notch target gene inhibition
is mediated by direct binding of BCL6 to
promoter and/or enhancer elements of
the corresponding gene (in this case
ESR1).
The importance of this publication goes
beyond establishing a novel role for BCL6
in LR patterning of Xenopus embryos. The
studies by Sakano et al. establish one of
the rare mechanistic explanations for
how transcription of selected Notch tar-
get genes can be inhibited, while others
remain activated, in order to establish
a proper developmental process. They
convincingly show that BCL6/BCoR acts
as a competitor for MAM1 in the protein
complex regulating ESR1 transcription
and thus confines the Notch signal to
cell-specific target genes. Future studies
will be necessary to investigate how the
Notch-ESR1 axis regulates Pitx2 geneDevelopmental Cell 1expression in more detail. It is however
conceivable that such a mechanism is
not only restricted to LR patterning but
might find its conservation in tissues
where Notch and BCL6 expression
patterns overlap to define specific devel-
opmental, homeostatic, or pathophysio-
logical processes.
It is worth noting that Notch, BCL6, and
BCoR have been linked to overlapping
sets of human leukemias and congenital
disorders. Correlative evidence connect-
ing BCL6 and Notch to human disease
was observed in diffuse large B cell
lymphoma, where Notch2 gain-of-func-
tion mutations and increased BCL6
protein expression are common (Lee
et al., 2009). In Hodgkin’s lymphoma cell
lines, BCoR is detected at a number of
BCL6 target genes, implying that BCoR
might play a role in mediating lymphoma-
genesis (Pasqualucci et al., 2003). In addi-
tion, mutations in the BCoR gene can
cause Oculofaciocardiodental syndrome,
which includes features of LR patterning
defects such as intestinal malrotation,
asplenia, and dextrocardia (Hilton et al.,
2007; Ng et al., 2004). These findings
suggest that some functions of BCL6/
BCoR transcriptional regulation are con-
served and may relate to Notch-depen-
dent processes in particular. The novel
mechanism described by Sakano and
colleagues to direct Notch-specific target
gene regulation via BCL6 thus opens new
and exciting avenues of research to
assess whether these regulatory mecha-
nisms will have a broader impact on other
developing, self-renewing, or cancerous
tissues.REFERENCES
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During development, skeletal muscles adapt to stage-specific functional and metabolic challenges by
switching the expression of specific subset of genes. Themechanism that governs these changes is still enig-
matic. In a recent issue of Cell, Messina and coworkers shed light on this issue through the identification of
a transcription factor—NFix—that coordinates the switch in gene expression at the transition from embryonic
to fetal myoblasts.Every transition in life requires that the
preexisting status be erased prior to
stepping into a new stage. For instance,
it is notoriously difficult to move into
a new relationship if the previous one
has not been resolved. An analogous situ-
ation applies to embryo development,
during the transition from one stage to
another. Skeletal myogenesis occurs in
successive steps, each of them involving
distinct progenitor cell types and specific
patterns of gene expression (Bryson-
Richardson and Currie, 2008). The first
muscle fibers in the embryo appear by
day e11 from the fusion of embryonic
myoblasts. By day 16 a second wave of
myogenesis is driven by fetal myoblasts,
which give rise to most of the adult mus-
culature. In postnatal life, muscle growth
and regeneration occurs at the expense
of a heterogeneous population of adult
muscle progenitors—the satellite cells.
Embryonic, fetal, and adult muscle pro-
genitors show different patterns of gene
expression that comply with stage-
specific activities (Gunning and Harde-
man, 1991). Switching on or off specific
subsets of genes at each transition is
therefore a critical challenge faced by
developmental myogenesis. Despite the
knowledge of the molecular networksthat specify the myogenic lineage and
activate skeletal myogenesis by the coop-
erative activity of different transcription
factors (Guasconi and Puri, 2009), the
identities of the cellular factors that coor-
dinate gene repression and activation at
each transition remains elusive. In a recent
Cell paper, Messina et al. (2010) demon-
strate that a single transcription factor—
nuclear factor I-x (Nfix)—is necessary
and sufficient to mediate the transcrip-
tional switch between embryonic and fetal
myogenesis.
Nfix belongs to a class of transcription
factors consisting of four closely related
genes—Nfia, Nffb, Nfic, and Nfix—that
are involved in the control of gene expres-
sion in a variety of cell types and tissues
(Gronostajski, 2000). Nfi-binding sites
have been implicated both in gene activa-
tion and repression, but the mechanism
by which they modulate transcription is
still obscure. Nfi proteins bind to DNA
either as homodimers or heterodimers
with other family members through an
N-terminal region; the C-terminal region
is highly variable, as the result of exten-
sive alternative splicing, and contains
domains responsible for transcriptional
activation or repression (Gronostajski,
2000). Mouse models in which theexpression of the different family mem-
bers has been ablated have revealed the
role of Nfia and Nfib in brain development
(with Nfib being also essential for lung
maturation) and of Nfic in correct tooth
formation. Nfix-deficient mice die soon
after birth with defects in brain, intestine,
and skeleton (Pekarik and Belmonte,
2008). Thus, the discovery by Messina
et al. (2010) that Nfix has a crucial role
in skeletal myogenesis is unanticipated.
A genome-wide screen in fetal versus
embryonic myoblasts, previously per-
formed by the same group, showed an
abundant and preferential expression of
Nfix in fetal myoblasts (Biressi et al.,
2007). Messina et al. (2010) now use
a combination of assays in established
and primary (embryonic or fetal) mouse
muscle cells to demonstrate the role of
Nfix in the activation of gene expression
typical of fetal myoblasts. In vivo experi-
ments show that conditional ablation of
Nfix in MyoD-expressing cells prevents
the initiation of fetal-specific transcription.
Consistently, premature expression of
Nfix in embryonic myoblasts leads to an
anticipated activation of fetal genes and
suppression of embryonic genes. This
evidence led the authors to conclude
that Nfix coordinates gene expression
